Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [ACTIVE] · [HEALTH]
2 clusters · 6 sources · 28 days · First seen · Last updated
Hepatitis Delta virus treatment developments
Overview
Recent developments in the management of chronic hepatitis delta virus (HDV) highlight a transition from a lack of approved therapies to an accelerating landscape of medical advancements.
Clinical research has shown progress with investigational treatments, such as the monoclonal antibody brelovitug. In the Phase 3 AZURE-1 trial, patients receiving brelovitug achieved combined virologic response and alanine aminotransferase (ALT) normalization at rates of 56% and 45% depending on dosage, compared to 0% in the delayed treatment group. This therapy aims to control the virus and liver inflammation to prevent progression to cirrhosis, liver failure, or liver cancer.
At the fifth International Delta Cure Meeting in Milan, experts noted that while HDV remains the most aggressive form of chronic viral hepatitis, the availability of treatments is increasing. Bulevirtide has emerged as the first specific treatment available in clinical practice, demonstrating virological and biochemical responses with a strong safety profile. Several other therapeutic strategies are currently in advanced stages of development.
Entities
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico · Mirum Pharmaceuticals · Heiner Wedemeyer · Hannover Medical School · Pietro Lampertico
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 3 SOURCES] The fifth International Delta Cure Meeting was held in Milan. www.ilgazzettinodigela.it · www.azsalute.it · www.lacronaca24.it
- [● 3 SOURCES] Hepatitis Delta is considered the most aggressive form of chronic viral hepatitis. www.ilgazzettinodigela.it · www.azsalute.it · www.lacronaca24.it
- [● 3 SOURCES] Bulevirtide is currently the only specific treatment available in clinical practice for chronic Hepatitis Delta. www.ilgazzettinodigela.it · www.azsalute.it · www.lacronaca24.it
- [● 3 SOURCES] There are numerous new therapeutic strategies for HDV in advanced stages of development. www.ilgazzettinodigela.it · www.azsalute.it · www.lacronaca24.it
- [● 3 SOURCES] In Italy, the number of patients with active HDV infection is estimated to be in the thousands. www.ilgazzettinodigela.it · www.azsalute.it · www.lacronaca24.it
- [○ 1 SOURCE] Bulevirtide has shown a good safety profile in patients with advanced liver disease. www.azsalute.it
Timeline
-
[HEALTH] 6 sourcesHepatitis Delta treatment landscape shifts at International Delta Cure Meeting
Experts at the International Delta Cure Meeting in Milan announced new advancements for Hepatitis Delta, including the availability of bulevirtide and several new therapies in advanced development.
-
[HEALTH] 6 sourcesMirum Pharmaceuticals reports positive Phase 3 results for hepatitis delta treatment
Mirum Pharmaceuticals' Phase 3 AZURE-1 trial for brelovitug met its primary endpoint, showing significant virologic response and ALT normalization in patients with chronic hepatitis delta virus.
Sources
azsalute.it · ilgazzettinodigela.it · ilpubblicista.it · lacronaca24.it · pugliain.net · quotidianodigela.it